MedGenome公司投资于绿十字遗传学,以扩大印度各地负担得起的基因组诊断。 MedGenome invests in Green Cross Genetics to expand affordable genomics diagnostics across India.

MedGenome是一家设在孟加拉的基因组学公司,对绿色十字遗传学实验室进行了大部分投资。 绿色十字遗传学实验室是以古吉拉特为基地的诊断链,拥有30多年的经验。 MedGenome, a Bengaluru-based genomics company, has made a majority investment in Green Cross Genetics Lab, a Gujarat-based diagnostics chain with over 30 years of experience. 该伙伴关系旨在扩大印度各地,特别是第2和第3级城市获得负担得起、基因组学驱动诊断的机会。 The partnership aims to expand access to affordable, genomics-driven diagnostics across India, especially in Tier 2 and Tier 3 cities. 通过将绿十字17个实验室,35个收集中心和临床专业知识与MedGenome的CAP认可的多种组学实验室和人工智能分析相结合,该合作旨在改善早期疾病检测和个性化护理. By combining Green Cross’s 17 labs, 35 collection centers, and clinical expertise with MedGenome’s CAP-accredited multiomics lab and AI-powered analysis, the collaboration seeks to improve early disease detection and personalized care.